SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001136261-18-000306
Filing Date
2018-11-13
Accepted
2018-11-09 18:46:25
Documents
4
Period of Report
2018-11-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K body8k.htm 8-K 11038
2 PRESS RELEASE exh99-1.htm EX-99.1 177676
3 LOGO image1904.jpg GRAPHIC 6415
4 LOGO image2388.gif GRAPHIC 6297
  Complete submission text file 0001136261-18-000306.txt   207699
Mailing Address 10 NORTH PARK PLACE SUITE 201 MORRISTOWN NJ 07960
Business Address 10 NORTH PARK PLACE SUITE 201 MORRISTOWN NJ 07960 (862) 260-8457
PERNIX THERAPEUTICS HOLDINGS, INC. (Filer) CIK: 0001024126 (see all company filings)

IRS No.: 330724736 | State of Incorp.: MD | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14494 | Film No.: 181174391
SIC: 2834 Pharmaceutical Preparations